These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22330810)

  • 1. The risks of PPI therapy.
    Moayyedi P; Leontiadis GI
    Nat Rev Gastroenterol Hepatol; 2012 Feb; 9(3):132-9. PubMed ID: 22330810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible risks of proton pump inhibitors.
    Gracie DJ; Ford AC
    Med J Aust; 2016 Oct; 205(7):292-3. PubMed ID: 27681962
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.
    Kanno T; Moayyedi P
    Curr Gastroenterol Rep; 2019 Dec; 21(12):65. PubMed ID: 31807948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors: potential adverse effects.
    Abraham NS
    Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
    Thurber KM; Otto AO; Stricker SL
    Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors, adverse events and increased risk of mortality.
    Lanas-Gimeno A; Hijos G; Lanas Á
    Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications of Proton Pump Inhibitor Therapy.
    Vaezi MF; Yang YX; Howden CW
    Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis.
    Kwok CS; Nijjar RS; Loke YK
    Drug Saf; 2011 Jan; 34(1):47-57. PubMed ID: 21047145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies.
    Wang CH; Li CH; Hsieh R; Fan CY; Hsu TC; Chang WC; Hsu WT; Lin YY; Lee CC
    Expert Opin Drug Saf; 2019 Mar; 18(3):163-172. PubMed ID: 30704306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest insights into the hot question of proton pump inhibitor safety - a narrative review.
    Savarino V; Marabotto E; Furnari M; Zingone F; Zentilin P; Savarino E
    Dig Liver Dis; 2020 Aug; 52(8):842-852. PubMed ID: 32513631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
    Laria A; Zoli A; Gremese E; Ferraccioli GF
    Reumatismo; 2011 Mar; 63(1):5-10. PubMed ID: 21509344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications and safety of proton pump inhibitor drug use in patients with cancer.
    Triadafilopoulos G; Roorda AK; Akiyama J
    Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors: Review of Emerging Concerns.
    Nehra AK; Alexander JA; Loftus CG; Nehra V
    Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.